Merck, Orna Therapeutics sign circular RNA collaboration deal valued at up to $3.65B
August 16, 2022 at 14:20 PM EDT
The companies will work together to discover, develop, and commercialize multiple oRNA programs, including vaccines and therapeutics, for infectious diseases and cancer.
